Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.20.2
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue
Operating expenses:        
Research and development, net of reimbursements 3,788 4,830 11,446 13,176
General and administrative 1,825 1,822 4,512 4,262
Total operating expenses 5,613 6,652 15,958 17,438
Loss from operations (5,613) (6,652) (15,958) (17,438)
Other income:        
Interest income - net 73 53 123 141
Total other income 73 53 123 141
Net loss (5,540) (6,599) (15,835) (17,297)
Deemed dividend for warrant down-round protection provision (1) (1)
Net loss applicable to common stockholders $ (5,540) $ (6,599) $ (15,836) $ (17,298)
Net loss per share of common stock – basic and diluted (in Dollars per share) $ (0.36) $ (1.21) $ (1.46) $ (3.60)
Weighted average shares of common stock outstanding, including outstanding pre-funded warrants– basic and diluted (in Shares) 15,432,857 5,444,600 10,875,712 4,802,398